Financhill
Back

Lyra Therapeutics Stock Predictions

Lyra Therapeutics Stock Forecast

  • Over the next 52 weeks, Lyra Therapeutics has on average historically fallen by 43.1% based on the past 5 years of stock performance.
  • Lyra Therapeutics has fallen lower in 5 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 100%
  • Is Lyra Therapeutics Stock Undervalued?
    The current Lyra Therapeutics [LYRA] share price is $9.00. The Score for LYRA is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
  • LYRA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Lyra Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Lyra Therapeutics has on average historically fallen by 43.1% based on the past 5 years of stock performance.

Lyra Therapeutics Stock Rating

Sell
32
Lyra Therapeutics (LYRA) is a Sell

Is Lyra Therapeutics overpriced?

  • Lyra Therapeutics has fallen lower in 5 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 100%

Lyra Therapeutics Stock Price History

Is LYRA stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LYRA is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
lyratherapeutics.com

52-Week Data

52-Week High:
37.50
52-Week Low:
3.81

Prediction Charts

Market Cap:
11.9M
Price in USD:
9.00
Volume:
43.5K
Beta:
0.23

Technical Analysis

SMA50:
9.32
SMA100:
8.62
SMA200:
9.78
52-Wk Change:
-35.71%

Stock Predictions

  • Is Lyra Therapeutics stock public?
    Yes, Lyra Therapeutics is a publicly traded company.
  • What is the Lyra Therapeutics stock quote today?
    The Lyra Therapeutics stock price is 9.00 USD today.
  • How to buy Lyra Therapeutics stock online?
    You can buy Lyra Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Jun-16 11.18 11.33 12.17 10.56
Jun-17 11.33 10.28 11.64 10.27
Jun-18 10.21 10.68 11.06 9.81
Jun-20 10.81 10.45 11.13 10.31
Jun-23 10.15 11.49 11.91 10.15
Jun-24 11.50 12.86 13.36 11.50
Jun-25 12.50 12.30 12.99 11.92
Jun-26 12.33 13.38 14.88 12.33
Jun-27 9.65 9.11 9.95 8.78
Jun-30 9.03 8.96 9.10 8.35
Jul-1 8.95 8.90 9.28 8.50
Jul-2 9.14 9.31 9.36 8.82
Jul-3 9.30 9.00 9.30 8.86
Jul-7 9.01 9.03 9.20 8.69

Lyra Therapeutics Earnings

Lyra Therapeutics Earnings Report: Per Share Lyra Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Lyra Therapeutics Forecast Revenue Growth

Lyra Therapeutics Stock Analysis: Historical quarterly revenues per share for Lyra Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $5.67 per share, a decrease next quarter of $0.00 per share, an increase this year of $42.75 per share, and an increase next year of $5.50 per share.

* Lyra Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.